| Website | takedacam.com |
| Category | BioTech |
| Phone | 44-(0)1223-477910 |
| info@takedacam.com | |
| Employees |
| TOTAL | $22.3M |
| FUNDING TOTAL | $22.3M |
| Venture Round, 1/05 Avlar BioVentures Merlin Biosciences Bio*One Capital | $9.38M |
| Series D, 7/06 Bio*One Capital Merlin Biosciences Avlar BioVentures | $13M |
Takeda Cambridge Limited (TCB) and its subsidiary TSP, have established world-class target identification and validation capabilities. Together they have developed a promising pipeline of novel drug discovery targets and compounds in key areas of unmet medical need such as CNS disorders, chronic pain and urology indications, endocrinology and metabolic-related diseases.
